LetterJournal of thoracic oncology : official publication of the International Association for the Study of Lung CancerPublished
A Response to the Letter to the Editor: "Lazertinib Versus Osimertinib in EGFR-Mutant NSCLC: Efficacy, Toxicity, and Unaddressed Clinical Gaps"
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- County
- Montgomery County
Publication record
- Type
- Letter
- Venue
- Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
- Published
- Topic
- Clinical care
- PubMed ID
- 41519528
- Added to directory
- Source checked